RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $195M
- YoY, 2025
- +35.1%
- 5-year CAGR
- +33.4%
- 10-year CAGR
- +49.8%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $195M | +35.1% |
| 2024 | $144M | +22.8% |
| 2023 | $118M | +27.7% |
| 2022 | $92M | +34.4% |
| 2021 | $68M | +48.5% |
| 2020 | $46M | +26.2% |
| 2019 | $37M | +30.2% |
| 2018 | $28M | +195.0% |
| 2017 | $9.5M | +50.8% |
| 2016 | $6.3M | +84.3% |
| 2015 | $3.4M | — |